On this page
FLOOR ACTION:
SF 2119– Controlled Substance Schedules
SF
2119 relates to controlled substances. It allows the Pharmacy Board to
change the schedule status of cannabis-derived products and cannabis-derived
investigational products based on decisions of the Food and Drug Administration
and the Federal Drug Enforcement Administration. The bill classifies nine
synthetic opioids, one opioid analgesic, 10 synthetic cannabinoids and seven
synthetic cathinones as Schedule I substances, meaning they have no known
medical use. It classifies all products containing derivatives of barbituric
acid as Schedule II. It classifies one central nervous system depressant and
one central nervous system stimulant as Schedule IV, and any FDA-approved
product containing cannabidiol with no more than 0.1 percent THC as Schedule V.
The bill also strikes language regarding medical marijuana programs at the
Board of Pharmacy.
[2/10: 48-0 (Excused: Nunn, T. Taylor)]
SF 2120– Prescription Monitoring Program
SF
2120 allows veterinarians to register for and access information from the state’s
Prescription Monitoring Program. Some veterinarians can prescribe controlled
substances, and there have been instances of pet owners taking the animal’s
medication. The bill also expands PMP reporting requirements to all Schedule
III and IV controlled substances and to all Schedule V controlled substances
except pseudoephedrine. Additional substances that the PMP Advisory Council and
Board of Pharmacy determine could be addictive or fatal are also included in
the required PMP reporting. The due date for the PMP annual reports is changed
to February 1 instead of January 1.
[2/10: 48-0 (Excused: Nunn, T. Taylor)]